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Background: The treadmill exercise test is the most important examination of the functional ability of patients with
intermittent claudication or leg pain during exercise, but it does not provide any metabolic information in the calf muscle.
The purpose of this study was to investigate the high-energy metabolism in the calf muscle during incremental progressive
plantar flexion exercise of a selected peripheral arterial disease (PAD) patient group.
Methods: Using a 1.5-T whole-body magnetic resonance scanner, 17 male patients with PAD who had 1 symptomatic and
1 asymptomatic leg and 9 healthy male controls underwent serial phosphor 31 (31P) magnetic resonance spectroscopy
during incremental exercise at 2, 3, 4, and 5 W. Furthermore, magnetic resonance angiography was performed, and the
ankle-brachial pressure index was determined in the patient group. The runoff resistance (ROR) was separately assessed
in each patient’s leg.
Results: The symptomatic legs exhibited significantly increased phosphocreatine (PCr) time constants during the first
three workload increments (2-4 W) and the recovery phase compared with the asymptomatic legs and the normal
controls. Only two symptomatic legs reached the last increment at 5 W. Compared with the normal controls, the
asymptomatic legs showed significantly increased PCr time constants only at 5 W. In the patient group, we detected
significant correlations between the PCr time constants and the ROR, as well as the ankle-brachial pressure index.
Moreover, the symptomatic legs presented significantly lower PCr levels and pH values at the end of exercise compared
with the asymptomatic and control legs.
Conclusions: Our study shows that muscle function in PAD patients can be objectively quantified with the help of 31P
magnetic resonance spectroscopy and correlates significantly with hemodynamic parameters such as ROR and ankle-
brachial pressure index. Consequently, 31P magnetic resonance spectroscopy seems to be a useful method to monitor the
muscle function of PAD patients for evaluation of established therapies or new therapeutic strategies during research
trials. ( J Vasc Surg 2006;43:978-86.)Intermittent claudication (IC) is the typical symptom
of patients with peripheral arterial disease (PAD).1 How-
ever, several epidemiologic studies have shown that the
prevalence of PAD ranges up to approximately 20%, de-
pending on the composition of the examined population,
whereas most PAD patients do not have classic IC symp-
toms and often present no symptoms or present atypical leg
pain that is difficult to distinguish from other entities.2-5
The clinical evaluation of PAD patients routinely includes
physical examination with peripheral pulse palpation,
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978ankle-brachial pressure index (ABPI), stress tests, several
imaging techniques, and the treadmill exercise test.6 The
treadmill test is the gold standard for the assessment of the
walking distance, which influences the clinical situation of
PAD patients and mainly determines further therapeutic
strategies. Nevertheless, several previous studies pointed
out that the treadmill test is affected by poor reproducibil-
ity,7 is often not conclusive because of the occurrence of
angina pectoris or dyspnea, or cannot be performed by the
patients because of comorbidity.8,9 Consequently, it is
difficult to quantify the functional and metabolic impair-
ment in the calf muscle due to atherosclerotic lesions. This
would be necessary to evaluate the effect of established or
experimental therapeutical interventions on muscle func-
tion or metabolism during research trials.
Phosphor 31 (31P) magnetic resonance spectroscopy
(MRS) has been established for the noninvasive investiga-
tion of mitochondrial capacity in skeletal and cardiac mus-
cle.10-12 At the onset of skeletal muscle exercise, phospho-
creatine (PCr) is hydrolyzed by the creatine kinase in the
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to adenosine diphosphate.13 The remaining creatine is
rephosphorylated at the mitochondrial site and is therefore
a shuttle of high-energy phosphates.13-15 The PCr concen-
tration decreases during muscle exercise until the oxygen
supply is adapted to meet the increased metabolic demand
of the mitochondria. In case of sufficient oxygen supply,
PCr hydrolysis passes into a steady state with a typical
monoexponential curve progression.16 Previous experi-
mental 31P MRS studies investigating the effect of cuff
stenosis or occlusion on intramuscular high-energy metab-
olism have shown that PCr hydrolysis progressively de-
creases under ischemic conditions.17,18 Furthermore, the
time constants of PCr rephosphorylation are prolonged
after plantar flexion exercises and cuff stenosis.19 Phosphor
31 MRS studies of PAD patients are rare. Two previous
studies investigated the high-energy phosphate metabolism
in the calf muscle of PAD patients during isometric exer-
cises.20,21 Both studies detected prolonged time constants
of PCr rephosphorylation after exercise, as already indi-
cated by several previous studies that calculated the PCr
recovery rate via the quotients of PCr and inorganic phos-
phate (Pi).22-25 However, the cause for this prolongation
was controversially discussed, and it was attributed to a
reduced oxygen supply due to atherosclerotic lesions20 or
mitochondrial impairment due to chronic ischemia.21
Because the previous 31P MRS studies were focused on
PCr recovery rather than the PCr on-kinetics during exer-
cise, the aim of this study was to investigate the high-energy
metabolism of the calf muscle during incremental plantar
flexion exercise of a selected PAD patient group that pre-
sented one symptomatic and one asymptomatic leg in
comparison to a healthy control group.
METHODS
Informed consent was obtained from all patients and
volunteers before they participated in the study. All exper-
iments were completed in accordance with the institutional
review board’s requirements.
Patient and control group. We enrolled 17 patients
with PAD Fontaine stage II onto this study. The median
age of the patients was 62.5 years (range, 53-74 years). All
patients were nondiabetic and had a symptomatic and an
asymptomatic leg. The symptomatic legs presented a typi-
cal walking distance limited by IC of the calf. The patients
underwent routine evaluation, including a history and
physical examination, measurement of the walking distance
with a treadmill test (3 km/h and 12% gradient angle), and
determination of the ABPI at rest. Furthermore, each pa-
tient received magnetic resonance angiography (MRA) of
both legs. In addition, nine healthy men agreed to partici-
pate in this study and underwent the exercise protocol. The
median age of the volunteers was 67 years (range, 53-79
years). None of them was specifically trained in sports. All of
themwere nonsmokers andnondiabetics anddid not have any
history of PAD symptoms or coronary artery disease. All
volunteers had a palpable extremity pulse and ABPIs of 1.0
or greater at rest and after active pedal plantar flexion.Equipment. The exercise bench (Fig 1) used for the
experiments was a modification of the pedal ergometer that
was recently described.10,11 The pedal ergometer consisted
of one pedal that was conjoint to a piston and a cylinder and
mounted on the middle of a wooden bench. The cylinder
was connected to an air pressure system for the exercise
protocol. The force, produced in the cylinder of the pedal
system by the air pressure, and the distance of pedal move-
ment were continuously recorded at the piston and the
suspension of the pedal. The force and distance parameters
during exercise were transmitted to a computer system that
controlled the air pressure in the pedal system to maintain a
constant power output during one workload level. One of
the subject’s feet was fixed on the foot pedal at 0° of plantar
flexion and restrained at the heel and at the dorsum of the
foot by 3-cm-wide straps. Two additional 3-cm-wide straps
were placed above the knee and on the lower leg to main-
tain the position of the calf muscle groups on the surface
coil that was integrated into the exercise bench. The foot
pedal permitted a plantar movement of 7 cm, and this
resulted in an end angle of 21°. The subject’s upper body
was locked in position by two shoulder belts. During the
exercise protocol, a metronome gave the frequency of
plantar flexions, and the subject was requested to perform
full flexions over the distance of 7 cm. Muscle exercises
were performed at a constant frequency of 30 plantar
flexions per minute. The power output during the different
increments was controlled by self-written software.
Exercise protocol. Each patient and volunteer per-
formed the same exercise protocol during 31P MRS mea-
surement: after 1 minute at rest, the exercise protocol
consisted of four consecutive exercise increments with 2, 3,
4, and 5 W, whereby each exercise increment lasted 4
minutes. The recovery time was 5 minutes. In both the
PAD patients and the volunteer, both legs were separately
measured, and the two exercise sessions were separated by a
rest interval of 1 hour at minimum.
Phosphor 31 MRS protocol. The spectroscopic
measurements were performed on a 1.5-T whole-body
magnetic resonance scanner (Magnetom VisionSymphony;
Siemens, Erlangen, Germany) by using a circular polarized
double resonator surface coil that permits the receipt of 1H
resonances at 63.5 MHz and 31P resonances at 25.8 MHz.
Fig 1. The self-built exercise bench permits isotonic stress exer-
cises of the calf muscle with a defined workload, which is measured
via force at the piston and via distance and is adjusted by a feedback
control system. The volunteer lying on the exercise bench indicates
the correct positioning for the phosphor 31 magnetic resonance
spectroscopy examination.The transmitter coil had a diameter of 21 cm, and the
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decay sequence with a repetition time of 1000milliseconds,
an echo time of 0.13 milliseconds, a flip angle of 90°, 15
averages, and an acquisition time of 15 seconds was used.
The nuclear Overhauser enhancement was applied to all
spectroscopic measurements.10,11
MRA protocol. MRAwas performed in all patients by
using a 1.5-T whole-body magnetic resonance scanner
(Magnetom VisionSymphony) and a dedicated MRA coil
covering the pelvis and both legs (Siemens). The MRA
images were acquired in three levels by using fast low angle
shot (FLASH) three-dimensional sequences and the mov-
ing bed technique. A three-phase gadobenate dimeglumine
(20 mL; Multihance; Bracco, Italy) was injected into the
cubital vein with the help of a commercially available mag-
netic resonance injector (Spectris; Medrad, Pittsburgh, Pa)
and monitored by the care bolus feature of our magnetic
resonance system. The FLASH three-dimensional se-
quences had a field of view of 420 mm, a matrix of 384 to
448, a repetition time of 6.2 milliseconds, an echo time of
2.3, a slice thickness of 0.8 to 1.2mm, a slab thickness of 96
to 128 mm, and an acceleration factor of 2 derived from
the integrated parallel imaging technique (iPAT) with a
generalized autocalibrating partially parallel acquisitions
(GRAPPA) algorithm. All FLASH three-dimensional se-
quences were acquired before and after three-phase gado-
linium administration (8 mL at 1.2 mL/s; 12 mL at 0.8
mL/s; and 30 mL of saline at 0.8 mL/s).
MRA analysis. The subtracted, contrast-enhanced
MRA volumes were processed with the help of maximum-
intensity projection and formed the three-dimensional
MRAs (Fig 2). An experienced radiologist determined the
runoff resistance (ROR) by using the angiographic scoring
system proposed by the Society for Vascular Surgery26 and
modified by Peterkin et al27 and Williams et al,24 whereby
Williams et al extended the score to suit the purpose of 31P
MRS studies in the calf muscle.
Outflow was divided into abdominal, pelvic, thigh, and
calf segments; the contribution of each segment to gastroc-
nemius and soleus perfusion was weighted equally (arbi-
trarily chosen to be 3). Individual vessels were weighted as
follows: (abdomen) common iliac artery, 3; (pelvis) internal
iliac artery, 1, and external iliac artery, 2; (thigh) deep
femoral artery, 1, and superficial femoral artery, 2; and
(calf) anterior tibial artery, 1, posterior tibial artery, 1,
peroneal artery, 0, and pedal arch, 1. The degree of occlu-
sion was classified as follows: 0, 0% to 19% stenosis; 1, 20%
to 49% diameter stenosis; 2, 50% to 99% stenosis; 2.5,
occlusion for less than half the length of the vessel; and 3,
occlusion for more than half of the length. The pedal arch
was graded as follows: 0, completely patent; 1.5, partially
occluded; and 3, little or no arch visualized. The resistance
across each segment was calculated by multiplying the
vessel weight by the degree of occlusion for each vessel in
the segment and adding 1 to allow for the intrinsic resis-
tance of the normal vessel. Total resistance was calculated
by summing the resistance of the four segments.Phosphor 31 MRS data analysis. The spectral data
were processed by using the commercial software package
provided by the manufacturer (Siemens). The peak areas of
PCr and Pi were fitted in the frequency domain. In addi-
tion, the positions of the peaks of PCr and Pi were deter-
Fig 2. Magnetic resonance angiogram of a 64-year-old patient of
the patient group who presented with a left symptomatic leg and a
right asymptomatic leg.mined. Because absolute concentrations were not calcu-
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corrected for partial saturation and the nuclear Overhauser
enhancement effects. Moreover, we assumed that the T1
relaxation times of the metabolites were constant through-
out each 31P MRS session.29 The changes in the metabo-
lites were determined as percentage changes in relation to
the rest integral of each metabolite. The intracellular pH
was calculated from the chemical shift of Pi according to the
equation11
pH 6.75 log(3.27) ⁄ (5.69), (1)
where  is the chemical shift of the Pi peak in parts per
million relative to PCr.
The time constants and PCrss values, meaning the
differences between baseline and steady-state PCr levels,
were calculated for each workload increment by using a
nonlinear regression analysis in SPSS 11.0 for Windows
(SPSS Inc, Chicago, Ill), as previously reported.28 For that
purpose, the last PCr integral of the preceding increment
was regarded as the baseline PCr value. Then the following
PCr integrals of the increment were normalized to the
averaged baseline PCr integral and expressed as percentage
changes. The six rest PCr values at the beginning of the
exercise protocol were averaged as baseline for the first
4.5-W increment. The time constant  and the PCrss
values were iteratively calculated by using the equation29
PCrt PCr0PCrss (1 et ⁄ ) (2)
for the increase in workload and PCr hydrolysis and the
equation
PCrt PCr0PCrss(1 et ⁄ ) (3)
for the decrease in workload and PCr recovery, where PCr0
is the baseline value, PCrt is the PCr value at the time t,
and PCrss is the difference between the baseline PCr value
and the estimated steady-state level. The coherence be-
tween the monoexponential model and the data of each
subject was described28 by a coefficient of determination r2:
r2 1 residual sum of squares ⁄
corrected sum of squares (4)
A coefficient r2 greater than 0.6 was considered an accept-
able fit, whereas a coefficient r2 less than 0.6 indicated a
weak agreement with a monoexponential model. The PCr
time courses of these increments were visually evaluated
with respect to a progressive PCr decrease without any
steady state.When a progressive PCr breakdownwas detected
within an increment, this progressive decrease was considered
a sign of exercise-induced ischemia. Because progressive PCr
decreases do not follow a monoexponential course, PCr
time constants were not calculated for those increments.
Statistical analysis. The data were tabulated in SPSS
11.0 for Windows. Because most of the data were not
normally distributed, as revealed by the Kolmogorov-
Smirnov test, nonparametric tests were used for further
statistical evaluation. The significance level was set at.05.
The Kruskal-Wallis test was used to evaluate significant
effects between the symptomatic and asymptomatic as wellas normal controls in the PCr time constants and PCrss
values during the different increments and recovery, as well
as in the ABPIs, ROR, and PCr levels at the end of exercise.
For post hoc testing, the Mann-Whitney U test was used
with a corrected significance level (.01). Regarding the
intramuscular pH, we statistically evaluated the values at
the end of exercise and during the recovery phase, because
we obtained the lowest pH values at these time points. For
that, we averaged the serial pH values to a time resolution
of 30 seconds and performed the Kruskal-Wallis test at each
time point, followed by the Mann-Whitney U test (cor-
rected significance level .01). Consequently, the PCr
time constants, the PCrss values, the ABPIs, the ROR, the
PCr levels at the end of exercise, and the pH values were
expressed as medians with description of the range. Fur-
thermore, the PCr time constants, the PCrss values, the
ABPIs, the RORs, and the pH values that showed signifi-
cant differences were correlated by using the Spearman
rank correlation coefficient r. A correlation coefficient r of
0.35 to 0.49 was interpreted empirically as low; 0.5 to 0.79,
as moderate; and 0.8 or greater, as high. Each coefficient r
was tested for significance by SPSS.
RESULTS
Clinical data. Each of the 17 patients with PAD who
were included into the exercise protocol had a symptomatic
and an asymptomatic leg. Between the patient group and
the healthy controls, we did not observe any significant
difference in age (P  .276). The ROR was significantly
higher in the symptomatic legs (median, 11.0; range, 5.0-
21.5) compared with the asymptomatic legs (median, 6.0;
range, 4.0-12.0; P .001). Furthermore, the symptomatic
legs (median, 0.72; range, 0.44-1.18) showed significantly
lower ABPI values compared with the asymptomatic legs
(median, 1.05; range, 0.77-1.21; P  .001). Four symp-
tomatic legs stopped the exercise protocol during the third
increment, and 11 legs did so during the fourth increment.
Two of the symptomatic legs succeeded at all increments.
Except for the last two legs, all symptomatic legs showed a
progressive PCr decrease during the increment of exercise
stop, as shown in Fig 3. For these increments of exercise
stop, we did not calculate a PCr time constant. All asymp-
tomatic legs and the legs of the healthy controls fulfilled the
entire exercise protocol.
Changes in PCr. We detected significant differences
in the PCr end-of-exercise level (Fig 3) between the symp-
tomatic (median, 52.17%; range, 22.47%-70.27%) and the
asymptomatic (median, 61.93%; range, 35.88%-73.90%; P
 .009) legs, as well as the normal controls (median,
66.98%; range, 52.41%-80.94%; P  .001), but not be-
tween the asymptomatic legs and the normal controls. The
calculation of the PCr time constants revealed a median
coefficient of determination r2 of 0.94 (range, 0.68-0.99)
for the symptomatic legs, of 0.92 (range, 0.64-0.99) for the
asymptomatic legs, and of 0.96 (range, 0.70-0.99) for the
healthy controls. We observed significant differences in PCr
time constants between the symptomatic and the asymp-
tomatic legs during the second and third increment and
in th
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two symptomatic legs succeeded at the fourth increment,
we abstained from a statistical evaluation of this increment.
Fig 3. Time course of phosphocreatine (PCr) during i
arterial disease patient whose magnetic resonance angiog
the progressive PCr decrease shortly before exercise stop
Fig 4. The boxplots present the PCrss values, meanin
and steady-state level, and the PCr time constants  for
Significant effects are marked.Compared with the normal controls, the PCr time con-stants of the symptomatic groups were significantly in-
creased during the first three increments and the recovery
phase (Fig 4). The asymptomatic legs and the normal
ental calf exercise at 2, 3, 4, and 5 W in the peripheral
s presented in Fig 2. Please note the lower PCr level and
e symptomatic left leg.
phosphocreatine (PCr) difference between the baseline
workload increment (1-4) and the recovery phase (rec).ncrem
ram ig the
eachcontrols showed significant differences only during the
nces a
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legs were significantly increased during the first three incre-
ments, but not during the recovery phase, compared with
the asymptomatic legs. Moreover, we detected significant
differences inPCrss between the symptomatic legs and the
normal controls during the first and third increments. We
did not observe any significant differences between the
asymptomatic legs and normal controls.
Changes in pH. We did not detect any significant
differences in intramuscular pH between the asymptomatic
legs and the normal controls during the entire exercise
protocol. Furthermore, the intramuscular pH of the symp-
tomatic legs did not significantly differ from that of the
asymptomatic legs and normal controls during first two
increments; the statistical evaluation of differences in pH
between the symptomatic legs and the remaining groups
was hampered by an increasing number of symptomatic
legs that stopped the exercise protocol. However, the in-
tramuscular pH at the end of exercise was significantly
lower in the symptomatic legs (median, 6.83; range, 6.67-
6.99) compared with the asymptomatic legs (6.91; range,
6.73-6.99; P .004) and the normal controls (6.93; range,
6.76-7.02; P  .003). As shown in Fig 5, these significant
differences were also detected during the first 150 seconds
of the recovery time.
Correlation of the parameter. In the patient group,
we detected a significant correlation between the RORs
and ABPIs (r  0.603; P  .001) (Fig 6). In addition, the
Fig 5. The boxplots show the pH changes over time du
atic, asymptomatic, and control legs). Significant differeRORs and ABPIs correlated significantly and moderatelywith the PCr time constants and the PCrss values of
different increments and the recovery, as demonstrated in
the Table. Furthermore, we obtained significant correla-
tions between the PCr levels at the end of exercise, the pH
at the end of exercise and during the first 150 s of recovery,
the RORs, and ABPIs, as also shown in the Table.
DISCUSSION
As already addressed in the introduction, a substantial
number of PAD patients exhibit atypical symptoms or no
symptoms.2-5 This range of atypical leg symptoms beyond the
classic IC symptoms is often difficult to distinguish fromother
differential diagnoses, such as degenerative spine diseases or
neuropathies, whereby PAD patients have significantly lower
muscle functioning compared with patients with leg pain and
without PAD.5 Most of the methods used in clinical routine
for the evaluation of PAD patients, such as peripheral pulse
palpation, ABPI, stress tests, or several imaging techniques,
reflect and quantify the hemodynamic impairment due to
artherosclerotic lesions.6 Only the treadmill exercise test eval-
uates themuscle function of PAD patients. However, this test
is based on the patients’ pain sensation during walking but
does not give any information about themetabolic changes in
the muscle groups that are involved during walking—mainly
the calf muscle. Therefore, an objective method for quantita-
tive determintation of muscle function is required for the
evaluation of improvements due to established or experimen-
tal therapeutic interventions. In this study we correlated the
he recovery phase, separately for each group (symptom-
re marked.ring tmetabolic changes with the ROR, which was established and
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conventional angiograms.24,26,27,30 Because the diagnostic
accuracy of MRAs is comparable to that of conventional
angiograms with respect to the evaluation of PAD,31,32 we
applied the ROR score to MRAs of our patient group and
detected a significant correlation between RORs and ABPIs.
Previous experimental 31P MRS studies detected progres-
sive breakdowns of PCr during exercise under cuff occlusion
or stenosis in healthy volunteers. This was interpreted as a sign
of ischemia within the muscle.17,18 Several previous studies
investigated muscle metabolism in PAD patients and were
focused on the PCr recovery after exhaustive exercise rather
than on PCr changes during a sophisticated exercise proto-
col.20-25 Only one previous study used two different workload
levels that were separated by a recovery phase.20 Two of these
previous studies examined the on-kinetics of PCr hydrolysis
during isometric exercise.20,21 However, isometric exercise of
the calf muscle is not a physiological condition and is not
comparable to isotonic exercise, such as walking.33,34 In con-
trast, we performed an incremental, isotonic exercise protocol
of the calf muscle, which leads to an increase in blood flow in
the feeding arteries.17,33 Accordingly, a recent study demon-
strated that the blood flow increases during isotonic muscle
exercise under varying grades of cuff stenoses compared with
baseline at rest but that it decreases with compression of the
superficial femoral artery compared with exercise without
stenosis.17 Similar results were observed in an experimental
study in dogs that demonstrated that the increase in muscle
perfusion due to contractile exercise decreases with stenosis
severity.35 Therefore, the increase in oxygen supply induced
by muscle exercise is limited by a peripheral stenosis and does
not adequately meet the metabolic demand, which obviously
depends on the severity of stenosis or exercise intensity. Con-
sequently, the PCr concentration further decreases progres-
sively until exercise stops or passes into a steady state with a
prolongation of the PCr time constant.17,18
In our study, the symptomatic legs of the PAD patients
Fig 6. The scatterplot shows the relationship between runoff
resistance (ROR) and ankle-brachial pressure index (ABPI) sepa-
rated for the symptomatic and asymptomatic legs.showed increased PCr time constants and extent of PCrchanges during the first three increments compared with
normal controls and asymptomatic legs. During the last
exercise increment, PCr time constants of only two symp-
tomatic legs could be calculated, so a statistical comparison
of these two legs was not useful. The remaining 15 symp-
tomatic legs were exhausted and showed a progressive PCr
decrease before exhaustion, as detected during visual in-
spection of the PCr time curves. Therefore, we were not
amazed to observe significantly lower PCr levels at the end
of exercise compared with the asymptomatic legs and the
healthy controls. This finding was already reported by the
previous 31P MRS studies that investigated PAD pa-
tients.20-25 Similar results were also observed by several
previous 31P MRS studies that investigated the effect of
hypoxia on muscle metabolism during isotonic exercise.
Under hypoxia, these studies detected lower PCr levels at
comparable time points of exercise and longer PCr recovery
times compared with normoxia.36,37
It is interesting to note that the asymptomatic legs
exhibited increased PCr time constants during the last
exercise increment compared with normal controls, thus
indicating that the asymptomatic legs, showing a median
ABPI of 1.05 with a range between 0.77 and 1.21 and a
Table. The Spearman correlation coefficients r indicate
the correlations between the runoff resistance (ROR) and
the ankle-brachial pressure indices (ABPI) and the
parameters of the high-energy phosphate metabolism.
R ROR ABPI PCrrec
$ PCrssrec
2
PCr2W
§ .28* 0.22*
PCr3W
§ .59† 0.45†
PCr4W
§ .39† 0.32*
PCr5W
§ .61† 0.62†
PCrrec
$ .56† 0.58†
PCrend
 .58† 0.36†
PCrss2w
1 .51† 0.39*
PCrss3w
1 .64† 0.38†
PCrss4w
1 .57† 0.51†
PCrss5w
1 .72† 0.64†
PCrssrec
2 .56† 0.34*
pHend
3 .45† 0.47† 0.64† 0.55†
pH30
4 .53† 0.42† 0.67† 0.63†
pH60
4 .53† 0.54† 0.67† 0.64†
pH90
4 .57† 0.56† 0.68† 0.63†
pH120
4 .48† 0.53† 0.49† 0.49†
pH150
4 .44† 0.43† 0.46† 0.44†
†Significant (p  .05).
*non significant.
§PCr time constants of the exercise increments with a work intensity ranging
from 2 to 5W.
$PCr time constant of recovery.
PCr level at the end of exercise.
1Differences between baseline PCr level at the beginning of each increment
and the steady-state PCr level during the work intensities ranging from 2 to
5W.
2Difference between baseline PCr level at the beginning of recovery and the
steady-state PCr level.
3pH value at the end of exercise.
4pH values at 30, 60, 90, 120 and 150 s of recovery.median ROR of 6.0 with a range between 4.0 and 12.0,
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sented abnormalities in PCr time constants at higher work-
loads compared with the symptomatic legs; this probably
means that the asymptomatic legs were less affected by
PAD than the symptomatic legs. Because the median AB-
PIs of most asymptomatic legs were in the normal range
and the performance on the treadmill test depended on the
symptomatic leg, which determines the overall walking
distance, the degree of PAD in the asymptomatic legs was
not recognized on routine clinical examination.
During recovery, we detected significant differences in
PCr time constants between the symptomatic legs and the
asymptomatic legs, as well as normal controls, but no
differences between the asymptomatic legs and the normal
controls and no significant differences in the extent of PCr
changes. Prolonged PCr recovery times after exhaustive
exercise in PAD patients are controversially discussed in the
literature. One aspect is the peripheral stenosis that limits
the blood flow and oxygen supply during exercise, when
the metabolic demand is increased and cannot be satisfied
by an appropriate increase in oxygen supply.20,35 A mito-
chondrial impairment due to chronic ischemia is also dis-
cussed in the literature as a possible explanation of the
increased PCr recovery rate21 and is further supported by
histologic evaluations of mitochondria in PAD patients
with altered mitochondrial function.38 However, the PCr
time constants and the extent of PCr changes during recov-
ery showed a significant correlation with the RORs and the
ABPIs, as already revealed for the exercise increments. Our
findings indicate a close correlation between the hemody-
namic parameters and PCr kinetics and appear to be similar
to the results obtained during muscle exercise under hyp-
oxia, especially the behaviour of PCr.36,37 In light of these
considerations, our results can be completely explained by a
lack of oxygen supply with increasing exercise intensity in
PAD patients.
The pH levels showed significant differences between the
symptomatic legs and the asymptomatic legs, as well as the
normal controls, at the end of exercise and during the first 150
seconds of the recovery phase, with a significant correlation to
the PCr recovery rate. Corresponding to our results, a recent
article39 indicated that the PCr level at the end of exercise and
the pH kinetics during recovery affect the PCr recovery rate.
When additionally considering that the [H] are principally
generated by the adenosine triphosphate hydrolysis during
muscle exercise, the extent of [H] generation depends on
thework intensity,which is also linearly related to the extent of
PCr hydrolysis.13,10 Therefore, the significant correlations
between PCr recovery rate and pH at the end of exercise and
during the first 150 seconds of recovery are not amazing.
Generally, the intramuscular pH reflects the balance among
the amount of adenosine triphosphate that has been hydro-
lyzed due to contraction, the capacity of oxidative rephospho-
rylation that binds [H], and the amount of [H] that has
been discharged from the cytosol to the extracellular space.13
In conclusion, our study demonstrated prolonged PCr
time constants and an increased amount of PCr hydrolysis in
PAD patients during exercise and recovery; these correlatedwith the RORs and, somewhat more weakly, with the ABPIs.
Furthermore, we observed impaired PCr time constants in
clinically asymptomatic legs of PAD patients at a work inten-
sity of 5 W compared with normal controls, thus indicating
that the asymptomatic legs were also diseased. Several previ-
ous studies investigating the effect of hypoxic muscle metab-
olism observed similar results, and this strongly suggests that
our findings were mainly caused by an impaired oxygen sup-
ply. However, we cannot clearly define the possible role of a
mitochondrial dysfunction due to chronic ischemia in our
patients. This should be a focus of future research by investi-
gating the effect of revascularization or angioplasty on high-
energy phosphate metabolism. In our opinion, it is important
to prove the benefit of different established and new therapies
on muscle metabolism and function, which might also con-
tribute to a further improvement of the limb amputation rate
in PAD patients.40
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